The Audit Committee assists the Board of Directors in overseeing the quality and integrity of the company's accounting, auditing, financial reporting processes, and financial controls practices.

The Audit Committee is responsible for reviewing the Company's financial reports, auditing and accounting policies and procedures, internal control systems, material asset or derivatives transactions, material lending funds, endorsements or guarantees, and offering or issuance of any equity-type securities.The Committee also monitors legal compliance and oversees the hiring or dismissal of an attesting CPA, among other responsibilities.

TaiMed's Audit Committee is composed entirely of independent Directors, and Professor Chin-Ting Chiu serves as the chairman of the committee. For details on the number of meetings held and individual attendance records, please refer to TaiMed' s Annual Report of the relevant year.

Chairman Chiu, Chin-Ting

  • MBA, National Taiwan University
  • Former chairman, Securities and Futures Investors Protection Center
  • Former member of Mediation Committee, Securities and Futures Investors Protection Cente

Member Howard S. Lee, Ph.D.

  • PhD in Chemistry, University of Southern California, USA
  • Chairman, TAHO Pharmceuticals, Ltd.
  • Chairman, Transwell Biotech CO., Ltd.

Member Gwo-Fong Lin, Ph.D

  • Doctor of Philosophy in Engineering, University of Pittsburgh
  • Distinguished Professor, National Taiwan University
  • Corresponding Member, International Academy of Engineering, Russi